Mr. Tillis (for himself, Mr. Budd, Mrs. Blackburn, Mr. Daines, and Mr. Lankford) introduced the following bill; which was read twice and referred to the Committee on Finance
To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. Ensuring Pathways to Innovative Cures Act of 2025. S. 832. 119th
Cong., 1st
sess., Introduced in Senate March 4, 2025. https://www.govinfo.gov/app/details/BILLS-119s832is.
APA
Congress, Senate (2025, March 4). Ensuring Pathways to Innovative Cures Act of 2025 (S. 832 (IS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119s832is.
MLA
United States, Congress, Senate. Ensuring Pathways to Innovative Cures Act of 2025. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119s832is. 119th Congress, S. 832, Introduced in Senate 4 Mar. 2025.
Bluebook
S.832 - 119th Congress (2025-2026): Ensuring Pathways to Innovative Cures Act of 2025, S.832, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119s832is.
